← Back to Search

Imaging Techniques for Aortic Aneurysm

N/A
Recruiting
Led By Houssam Farres, MD
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Patients with non-aneurysmal aortas who require aortic contrast imaging or echocardiography for preoperative planning or other reason
Patients with non-aneurysmal aortas who require aortic contrast imaging or echocardiography for preoperative planning or other reason.
Must not have
Patients with contraindication to IV contrast such as allergy or severe kidney dysfunction
Patients who do not require contrast imaging or echocardiogram as part of their care plan
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from baseline ecg-gated imaging measurements.
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing whether two new imaging methods can accurately measure the stiffness of the aorta.

Who is the study for?
This trial is for adults over 18 who can consent and need aortic imaging or echocardiography, including those with abdominal aortic aneurysms (AAA) that are larger than normal. It's not for those without imaging needs, with IV contrast allergies or severe kidney issues, terminally ill patients, or those unable to undergo MRI.
What is being tested?
The study tests the feasibility of using two new imaging methods—ECHO and ECG-gated MRA—to measure the biomechanical properties of healthy and aneurysmal aortas in various patients.
What are the potential side effects?
While this study focuses on imaging techniques rather than drug interventions, potential side effects may include discomfort from lying still during scans and risks associated with exposure to contrast agents if applicable.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I need special heart imaging but don't have an aortic aneurysm.
Select...
I need imaging for my heart or aorta for surgery planning or another reason, and I don't have an aortic aneurysm.
Select...
My aorta is at least 1.5 times its normal size.
Select...
My aorta is at least 1.5 times its normal size.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I cannot have IV contrast due to an allergy or severe kidney issues.
Select...
I don't need dye imaging or heart ultrasound for my treatment.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from baseline in echo imaging measurements
This trial's timeline: 3 weeks for screening, Varies for treatment, and change from baseline in echo imaging measurements for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
ECHO Imaging
Secondary study objectives
ECG-gated MRA Imaging

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

3Treatment groups
Active Control
Group I: Surgery-EVARActive Control2 Interventions
EVAR with ECHO and ECG-gated MRA imaging.
Group II: Surgery-OpenActive Control2 Interventions
Open Surgery with ECHO and ECG-gated MRA imaging.
Group III: SurveillanceActive Control2 Interventions
No Surgery with ECHO and ECG-gated MRA imaging.

Find a Location

Who is running the clinical trial?

Mayo ClinicLead Sponsor
3,343 Previous Clinical Trials
3,062,319 Total Patients Enrolled
Houssam Farres, MDPrincipal Investigator - Mayo Clinic
Mayo Clinic Hospital Jacksonville
4 Previous Clinical Trials
77 Total Patients Enrolled

Media Library

Surgery-EVAR Clinical Trial Eligibility Overview. Trial Name: NCT02548546 — N/A
Abdominal Aortic Aneurysm Research Study Groups: Surgery-EVAR, Surgery-Open, Surveillance
Abdominal Aortic Aneurysm Clinical Trial 2023: Surgery-EVAR Highlights & Side Effects. Trial Name: NCT02548546 — N/A
Surgery-EVAR 2023 Treatment Timeline for Medical Study. Trial Name: NCT02548546 — N/A
~5 spots leftby Aug 2026